Intravenous tissue plasminogen activator for ischemic stroke in early pregnancy dosed by actual body weight.

We present positive outcomes of a mother and fetus after receipt of intravenous tissue plasminogen activator using actual body weight during the first trimester of pregnancy for an acute ischemic stroke. Additional information is necessary to provide recommendations for the application to future patients in early pregnancy.